The 5 best and 5 worst pharma deals of the decade: Leerink - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 51%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

RANKED: Here are the best and worst pharma deals of the past decade, and why they tanked or triumphed

Astrid Stawiarz / CNBCsimply click here to claim your deal and get access to all exclusive Business Insider PRIME content.Analysts from SVB Leerink rounded up the five best and the five worst pharma deals of the last decade.

One of the best deals was Merck acquiring Schering-Plough for $41 billion in 2009, with one of the worst deals being Johnson & Johnson's $30 billion acquisition of Actelion in 2017, according to the Leerink analystsOver the past 10 years, dealmaking has reshaped the pharmaceutical industry. Facing generic competition for once-blockbuster drugs and new pricing threats, many a deal got done to fill in key gaps in a company's portfolio — some more successfully than others.

Analysts at SVB Leerink rounded up the five best and the five worst acquisitions of the last decade. The list of best and worst deals are based on an analysis of all the transactions over the last decade along with the input of the SVB Leerink therapeutics research team, and it shines some light on the often binary nature of biotech dealmaking.

The analysts found overall that deals with a transaction value of $1 billion to $5 billion have the highest success rate, compared to lower success rates for larger transactions. The analysts note that deals within the oncology space had two times the success rate as deals in other therapeutic areas.

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 729. in RU
 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Plaid CEO on hiring best talent for US fintech unicorn startup - Business InsiderThe CEO of a US fintech unicorn worth more than $2.6 billion spends a third of his time recruiting. Here's why he 'hires for spikes' rather than seeking well-rounded candidates.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Best Buy to offer free next-day delivery for holidays - Business InsiderBest Buy is offering its customers the option for free next-day delivery on thousands of products this holiday season.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

The 8 best YouTube cooking channels to get ready for Thanksgiving - Business InsiderAs the holidays rapidly approach, get yourself ready for holiday cooking with these excellent YouTube channels.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Plaid CEO on hiring best talent for US fintech unicorn startup - Business InsiderThe San Francisco-based fintech hired 200 people between June 2018 and 2019 and is hiring around 230 people across the US and Europe. Ho. Great
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Best earnings season options trades from JPMorgan quant guru Kolanovic - Business InsiderJPMorgan's Marko Kolanovic moves markets with his research. These are his 'favorite' trades to profit from earnings-season volatility. That’s Rob Riggle abel92G benjamin_sombi
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Popeyes' new pumpkin pie is best fast-food dessert: review - Business InsiderPopeyes still doesn't have the chicken sandwich, but it does have a delicious new deep-fried pumpkin and cream cheese pie. Run, don't walk.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »